Novelix Pharmaceuticals Board Meeting on Nov 11 for Q2 Results

Novelix Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 11, 2026, to approve the unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The meeting will also include a review of the limited review report from the auditors. In line with SEBI regulations, the trading window for designated persons and their immediate relatives will be closed from October 1, 2026, until 48 hours after the board meeting concludes.